Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Total 13F shares
-
23,249,529
-
Share change
-
+9,478,690
-
Total reported value
-
$7,814,136
-
Price per share
-
$0.34
-
Number of holders
-
11
-
Value change
-
+$3,181,319
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q2 2024
As of 30 Jun 2024,
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,249,529 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), JOHNSON & JOHNSON, 8VC GP I, LLC, BARCLAYS PLC, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, XTX Topco Ltd, Raymond James Financial Services Advisors, Inc., and PNC Financial Services Group, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.